(HealthDay)—Rupture of the distal biceps tendon (RBT) in a patient with heart failure with preserved ejection fraction should raise suspicion for wild-type transthyretin amyloidosis (ATTRwt), according to a research letter ...
Sep 13, 2017
0
3
Medication, including beta-blockers, may be so effective in reducing the risk of sudden death in heart failure that the overall benefit of implantable cardioverter-defibrillators (ICDs) may be uncertain
Jul 6, 2017
0
2
Diesel pollution is linked with heart damage, according to research presented today at EuroCMR 2017.
May 26, 2017
0
0
Researchers have completed a randomized clinical trial in patients with heart failure with preserved ejection fraction (HFpEF), which currently has no effective treatment for reducing morbidity and mortality.
Apr 30, 2017
0
0
Lifestyle patterns, including physical activity and body mass index (BMI), are associated with a risk of overall heart failure but are more strongly associated with the heart failure subtype HFpEF, according to a study published ...
Feb 27, 2017
0
0
The heart is a wonder of design - a pump that can function for 80 years, and billions of heartbeats, without breaking down. But when it does malfunction, the results can be dire.
Jan 30, 2017
0
0
(HealthDay)—For patients with heart failure with preserved ejection fraction (HFpEF) with an exercise-induced increase in the ratio between early mitral inflow velocity and mitral annular early diastolic velocity (E/e'), ...
Oct 18, 2016
0
0
Sacubitril-valsartan is reasonably cost effective compared to widely-used therapies for reducing mortality and morbidity in patients with reduced ejection fraction heart failure. The findings are published in Annals of Internal ...
Aug 29, 2016
0
0
Heart failure with preserved ejection fraction (HFpEF) has been particularly difficult to treat, or even describe, with definitions and terminology still under debate within the medical community. The number of patients hospitalized ...
Jul 26, 2016
0
0
A UCLA-led study estimates that almost 28,500 deaths could be prevented each year in the U.S. through use of a new FDA-approved class of cardiovascular medication that helps reduce mortality in patients diagnosed with heart ...
Jun 22, 2016
0
1
